tiprankstipranks
Trending News
More News >
HitIQ Limited (AU:HIQ)
:HIQ
Australian Market
Advertisement

HitIQ Limited (HIQ) Price & Analysis

Compare
3 Followers

HIQ Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

19.61%80.39%
19.61% Insiders
Mutual Funds
― Other Institutional Investors
80.39% Public Companies and
Individual Investors

HIQ FAQ

What was HitIQ Limited’s price range in the past 12 months?
HitIQ Limited lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
    What is HitIQ Limited’s market cap?
    HitIQ Limited’s market cap is AU$7.40M.
      When is HitIQ Limited’s upcoming earnings report date?
      HitIQ Limited’s upcoming earnings report date is Aug 28, 2025 which is in 41 days.
        How were HitIQ Limited’s earnings last quarter?
        Currently, no data Available
        Is HitIQ Limited overvalued?
        According to Wall Street analysts HitIQ Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does HitIQ Limited pay dividends?
          HitIQ Limited does not currently pay dividends.
          What is HitIQ Limited’s EPS estimate?
          HitIQ Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does HitIQ Limited have?
          HitIQ Limited has 493,157,000 shares outstanding.
            What happened to HitIQ Limited’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of HitIQ Limited?
            Currently, no hedge funds are holding shares in AU:HIQ

            Company Description

            HitIQ Limited

            HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care. The company was incorporated in 2015 and is based in Melbourne, Australia.
            Similar Stocks
            Company
            Price & Change
            Follow
            Global Health Limited
            Resonance Health Ltd
            Singular Health Group Ltd
            Emyria Ltd
            InteliCare Holdings Limited
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis